Home
>
National Drug Code (NDC)
>
IFOSFAMIDE
IFOSFAMIDE - 10019-926-02 - (IFOSFAMIDE)
Drug Information of IFOSFAMIDE
| Product NDC: | 10019-926 |
| Proprietary Name: | IFOSFAMIDE |
| Non Proprietary Name: | IFOSFAMIDE |
| Active Ingredient(s): | 3 g/60mL & nbsp; IFOSFAMIDE |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of IFOSFAMIDE
| Product NDC: | 10019-926 |
| Labeler Name: | Baxter Healthcare Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019763 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19881230 |
Package Information of IFOSFAMIDE
| Package NDC: | 10019-926-02 |
| Package Description: | 1 VIAL, SINGLE-DOSE in 1 CARTON (10019-926-02) > 60 mL in 1 VIAL, SINGLE-DOSE (10019-926-16) |
NDC Information of IFOSFAMIDE
| NDC Code | 10019-926-02 |
| Proprietary Name | IFOSFAMIDE |
| Package Description | 1 VIAL, SINGLE-DOSE in 1 CARTON (10019-926-02) > 60 mL in 1 VIAL, SINGLE-DOSE (10019-926-16) |
| Product NDC | 10019-926 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | IFOSFAMIDE |
| Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19881230 |
| Marketing Category Name | NDA |
| Labeler Name | Baxter Healthcare Corporation |
| Substance Name | IFOSFAMIDE |
| Strength Number | 3 |
| Strength Unit | g/60mL |
| Pharmaceutical Classes | Alkylating Activity [MoA],Alkylating Drug [EPC] |
